Intranasal Administration of Bedaquiline-Loaded Fucosylated Liposomes Provides Anti-Tubercular Activity while Reducing the Potential for Systemic Side Effects.

ACS Infect Dis · 2024 · PMC11406518 · PMID 39136125

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

While the performance of BDQ-Lipo fuc was not significantly better than that of the solubilized drug ( p = 0.0626), the results also showed a trend in this direction.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.